Location History:
- Royerford, PA (US) (2011)
- Royersford, PA (US) (2002 - 2017)
Company Filing History:
6 out of 2,078 
1 out of 363 
2 out of 832,891 Years Active: 2002-2017
Title: The Innovations of Raul R. Calvo: Pioneering TRPM8 Receptor Modulators
Introduction
Raul R. Calvo, an inventive mind based in Royersford, PA, is recognized for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of 9 patents, Calvo has primarily focused on developing substituted aza-bicyclic imidazole derivatives, which hold promise in treating various medical conditions.
Latest Patents
Among his latest patents are innovative compounds that act as TRPM8 receptor modulators. The inventions are directed toward pharmaceutical compositions that include substituted aza-bicyclic imidazole derivatives. These compositions are geared towards treating disorders modulated by the TRP M8 channel, which includes inflammatory pain, neuropathic pain, and conditions like inflammatory hyperalgesia. Furthermore, his research addresses cardiovascular diseases and respiratory ailments aggravated by cold conditions.
Career Highlights
Calvo has made notable strides in the pharmaceutical industry, with a significant tenure at Janssen Pharmaceutica, a respected global leader in healthcare. His work has contributed to the advancement of medical treatments that target complex pain pathways and other critical physiological functions.
Collaborations
Throughout his career, Raul has collaborated with esteemed colleagues, including Mark R. Player and Daniel J. Parks. These partnerships have enhanced the development and refinement of his innovations, helping to bring groundbreaking therapeutic solutions to fruition.
Conclusion
Raul R. Calvo stands out as an influential inventor whose work in the field of TRPM8 receptor modulators offers hope for a variety of medical conditions. His extensive patent portfolio underscores his dedication to innovation and excellence in pharmaceutical research and development.